On October 20, 2025, XORTX Therapeutics Inc. filed its Form 6-K to report compliance with SEC regulations. This filing is significant as it denotes adherence to required reporting standards for foreign issuers.
AI Assistant
XORTX THERAPEUTICS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.